FDAFDA · Food and drugs·Recall number D-0468-2024
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Published May 1, 2024 · Recall initiated: April 9, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ABILIFY
- Manufacturer
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Distributor
- USA nationwide.
- Lot
- Lot # AMS00223A, Exp 07/31/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Japan
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.